Skip to main content
PureTech Health plc logo

PureTech Health plc — Investor Relations & Filings

Ticker · PRTC ISIN · GB00BPVG5C82 LEI · 213800LVPDNO2Z9T9I39 IL Manufacturing
Open in API
Filings indexed 1,319 across all filing types
Latest filing 2023-12-08 Transaction in Own Shar…
Country GB United Kingdom
Listing IL PRTC

About PureTech Health plc

https://puretechhealth.com/

PureTech Health is a clinical-stage biotherapeutics company dedicated to discovering, developing, and commercializing new classes of medicine for devastating diseases. The company's research and development engine focuses on advancing novel treatments by enhancing on-target efficacy, improving tolerability, or enabling oral administration of therapeutics with validated mechanisms. Its pipeline includes wholly-owned therapeutic candidates targeting a range of conditions, including idiopathic pulmonary fibrosis, neuropsychiatric disorders, and various cancers.

Recent filings

Filing Released Lang Actions
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document explicitly states its purpose in the title section: "PureTech Health PLC ... Transaction in Own Shares". It details the purchase of ordinary shares as part of a Share Buyback Programme, including the date, volume, and price range. This directly corresponds to the definition of 'Transaction in Own Shares' (Code: POS). The document is also flagged as an RNS filing, but the specific content dictates the more precise classification of POS.
2023-12-08 English
New LYT-200 Solid Tumors Data Presented at ESMO-IO
Regulatory Filings Classification · 98% confidence The document is a press release issued on December 7, 2023, identified by the RNS Number (9545V) and the distribution method (National Storage Mechanism, RNS). The content announces clinical trial data presentation (Phase 1 trial of LYT-200) at a medical congress (ESMO Immuno-Oncology Congress 2023). This type of announcement, which communicates material business or clinical development updates via a regulatory news service (RNS), fits best under the general 'Regulatory Filings' category, as it is not a full financial report (10-K, IR), a specific management change (MANG), or a dividend notice (DIV). While it is an announcement, it is not explicitly announcing the *publication* of a formal report like an Annual Report or Quarterly Report, but rather the presentation of data. Therefore, RNS is the most appropriate classification for this type of general regulatory news release.
2023-12-07 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document explicitly states its purpose in the title section: "Transaction in Own Shares". It details the purchase of ordinary shares as part of a "Share Buyback Programme" on a specific date (06 December 2023), including volume, high, low, and VWAP prices. This directly corresponds to the definition of a Transaction in Own Shares report, which is classified as Code: POS (Share Repurchase/Issuance). The presence of the RNS Number and the footer referencing the London Stock Exchange and FCA confirms it is a regulatory disclosure, but the content is specific enough to use the more precise POS code.
2023-12-07 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document is explicitly titled 'Transaction in Own Shares' and details the purchase of ordinary shares by PureTech Health PLC as part of its 'Share Buyback Programme'. It provides specific transaction dates, volumes, and prices. This directly corresponds to the definition of 'Transaction in Own Shares' (Code: POS), which covers company share repurchases.
2023-12-06 English
6-K
Transaction in Own Shares Classification · 100% confidence The document is a Form 6-K filed by a foreign private issuer, PureTech Health plc, reporting on its share repurchase program activity during November 2023. It details daily purchases of the company's own shares under the program, including quantities and prices, and references regulatory compliance with UK Listing Rules and EU regulations. The content focuses on the company's transactions in its own shares, specifically buybacks, rather than financial results, management changes, or other report types. The document length is 6617 characters, which is sufficient to contain substantive transaction data. Therefore, this filing is best classified as a Transaction in Own Shares (POS) report, which covers company buyback activities.
2023-12-05 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document explicitly states its purpose in the title section: 'PureTech Health PLC Transaction in Own Shares'. It details the purchase of ordinary shares as part of a 'Share Buyback Programme' on a specific date (04 December 2023), including volume, highest, lowest, and VWAP prices. This directly corresponds to the definition of 'Transaction in Own Shares' (Code: POS), which covers share repurchase/issuance activities.
2023-12-05 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.